The ACR’s recent introduction of the “cmbX” designation in the Dose Index Registry (DIR) is a meaningful step forward. By separating combination studies, the DIR now allows for more accurate mapping to combination RPIDs—or, when necessary, assignment to RPID88 to remove them from the “unmapped” category. But as many facilities are now discovering, this improvement… Read More